Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Here are today’s top growth stocks that have just been added to the IBD stock lists, including the IBD 50, IBD Big Cap 20 and Stock Spotlight The post Microsoft Rises, Defying Weak Market; Leads 17 To Top Growth Stock…
Sellers hit the stock market again ahead of a key inflation report Friday. Copper stocks sold off, but Apple soared in the Dow Jones. The post Stock Market Trips With Nasdaq Making Key Test Before CPI Report; Apple Shines appeared…
The S&P 500 undercut its 50-day as Treasury yields and oil prices surged. Oracle jumped late on earnings. The CPI inflation report could lock in expectations for a Fed rate hike next week. The post Dow Jones Futures: S&P 500…
Oracle stock jumped late Thursday after the tech giant reported fiscal first-quarter results that beat expectations. The post Oracle Stock Jumps As Earnings Beat Estimates, Cloud Infrastructure Growth Accelerates appeared first on Investor’s Business Daily.
Joe Fahmy explains how to trade choppy markets conditions with four essential investing rules. The post How To Navigate Sideways Markets: Joe Fahmy Shares His Four Core Trading Rules appeared first on Investor’s Business Daily.
At Investor’s Business Daily, we use artificial intelligence tools to help generate concise summaries for select pieces of our human-created content. This technology allows us to highlight key takeaways and… Read More The post How IBD Uses AI appeared first…
Welcome to IBD Live! This list of FAQs and useful links will speed your learning curve. The Ready List contains top stocks that meet our fundamental and technical screening criteria that are in or… Read More The post IBD Live Q&A Summary, Stock Lists…
Apple is the IBD Stock Of The Day after the consumer electronics giant earned high marks for its new product launch event. The post Apple, IBD Stock Of The Day, Rebounds Bullishly After iPhone Duo Debut appeared first on Investor’s…
Global spending on “clean” energy and tech plunged in the first half of 2026, but that’s not the full story. The post ‘Clean’ Energy And Tech Spending Slides 17%. New Report Blames China, But Doesn’t Tell The Whole Story. appeared…
Biotech leader Kiniksa stock is poised to hit a fresh buy point after shares soared 25% in response to better-than-expected sales numbers. The post Biopharmaceutical Leader Kiniksa Poised To Hit New Buy Point After Big Revenue Beat appeared first on…
